Collen Masimirembwa

Papers

Total Citations

219

H-Index

About

Collen Masimirembwa is a pioneering figure in pharmacogenomics and drug metabolism, with a particular focus on African populations. His research centers on understanding genetic variations in drug-metabolizing enzymes, such as cytochrome P450s, and their impact on drug safety and efficacy. Masimirembwa’s major contributions include elucidating how ethnic-specific genetic polymorphisms influence drug response, which is critical for personalized medicine in Africa. His highly cited 2003 work, "Metabolic Stability for Drug Discovery and Development" (219 citations), has become a foundational reference for assessing drug metabolism early in the development pipeline. Beyond this, he has led groundbreaking studies on the pharmacogenetics of antimalarials and antiretrovirals, directly addressing health disparities. As the founder of the African Pharmacogenomics Network and a director at the African Institute of Biomedical Science and Technology, his work has shaped global understanding of how genetic diversity affects therapeutic outcomes. With over 4,000 citations, Masimirembwa’s research continues to drive the integration of genomics into clinical practice, making him a key voice in advancing equitable healthcare through precision medicine.